LV-CAG-FLPo

Product Category: Pre-made recombinant lentivirus | LV-CAG-FLPo | LV-CBA-FLPo | CAG-FLPo Lentivirus | CBA-FLPo Lentivirus
Description: FLP originally identified from Saccharomyces cerevisiae is a site-specific recombinase (SSR) from the λ integrase family and recognizes distinct 34 bp FRT sequence. It has been widely used for generating conditional knockout mice, mediated by the FLP/FRT system. Initial use of FLP in mammalian cells revealed inefficient recombinase activity due to the thermo-instability of the FLP protein. Subsequent screening for thermo-stable mutants resulted in the identification of FLPe, which was a 4-fold increase in recombination efficiency at 37 °C. However, the recombination efficiency of FLPe in cells remains very low because of its non-mammalian origin.
FLPo is a mouse codon-optimized FLPe that greatly increases the FRT recombination efficiency for both in vivo and in vitro in mice. The LV-CAG-Puro is a pre-made lentivirus that over-expresses the FLPo recombinase upon infection of the mammalian cells. Ready to use format.
Titer: >1E+9 TU/mL
Selection Antibiotic: None
Purity*: In vivo grade and OK for both in vitro tissue culture infection and in vivo injection
CITATIONS
| Shipping Weight | 6 lbs |
|---|---|
| Unit Size | 2 x 25 µL at >10⁹ TU/mL, 25 µL at >10⁹ TU/mL |
Custom Service Solutions
Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.

